
	Three Months Ended
		March 31, 2026		March 31, 2025
Net income attributable to shareholders of Criteo S.A.		$	7,817	$	37,928
Weighted average number of shares outstanding of Criteo S.A.		50,352,465		53,979,157
Basic earnings per share		$	0.16	$	0.70

Diluted EPS considers the impact of potentially dilutive shares not yet issued from share-based compensation plans using the treasury stock method. There were no other potentially dilutive instruments outstanding as of March 31, 2026 and 2025. Consequently, all potential dilutive effects from shares are considered.

For each period presented, a contract to issue a certain number of shares (i.e., stock options and nonemployee warrants) was assessed as potentially dilutive if it was “in the money” (i.e., the exercise or settlement price is lower than the average market price).


	Three Months Ended
		March 31, 2026		March 31, 2025
Net income attributable to shareholders of Criteo S.A.		$	7,817	$	37,928
Basic shares:
Weighted average number of shares outstanding of Criteo S.A.		50,352,465		53,979,157
Dilutive effect of:
RSUs and PSUs		613,468		3,079,762

Stock options		—		82,956
Share warrants		—		54,023
Diluted shares:
Weighted average number of shares outstanding used to determine diluted earnings per share		50,965,933		57,195,898
Diluted earnings per share		$	0.15	$	0.66

The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:


	Three Months Ended
	March 31, 2026	March 31, 2025
Restricted share awards	1,995,016	33,092

Weighted average number of anti-dilutive securities excluded from diluted earnings per share	1,995,016	33,092